Meeting
2023 ASCO Annual Meeting
A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART) SWOG S1609: The vulvar cancers.
Authors
Young Kwang Chae
Northwestern University, Chicago, IL
Young Kwang Chae , Megan Othus , Sandip Pravin Patel , Robert P. Edwards , Jennifer Michelle Scalici , Liam Il-Young Chung , Christine McLeod , Helen X. Chen , Elad Sharon , Howard Streicher , Christopher W. Ryan , Charles David Blanke , Razelle Kurzrock
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Other Gynecologic Cancer
Clinical Trial Registration Number
NCT02834013
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 5517)
DOI
10.1200/JCO.2023.41.16_suppl.5517
Abstract #
5517
Poster Bd #
211
Abstract Disclosures
Similar Posters
First Author: Young Kwang Chae
Poster
2019 ASCO Annual Meeting
SWOG 1609 (DART): A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors.
First Author: Sandip Pravin Patel
Poster
2023 ASCO Annual Meeting
Interim analysis of a phase II study of nivolumab/ipilimumab plus cabozantinib in patients with unresectable advanced melanoma.
First Author: Geoffrey Thomas Gibney
Poster
2020 ASCO Virtual Scientific Program
A multicenter phase II study of nivolumab +/- ipilimumab for patients with metastatic sarcoma (Alliance A091401): Results of expansion cohorts.
First Author: James Lin Chen